Recruiting

Narrow-angle vs. Wide-angle

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT06373354

Conditions

Architectural Distortions

Breast Tomosynthesis

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Digital Breast Tomosynthesis (DBT)

Study Details

Brief summary:

To compare narrow-angle digital breast tomosynthesis (DBT) and wide-angle DBT.

Conditions

Architectural Distortions

Breast Tomosynthesis

Study ID

NCT06373354

Start date

Oct 18, 2024

Status verified date

Apr, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Dec 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Women undergoing standard screening mammography.
  • Ability to understand and sign consent.

Exclusion Criteria:

  • Pregnant women.
  • Women unable to consent.
  • Male patients.

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Arms

Digital Breast Tomosynthesis (DBT)

Participants that agree to take part in this study, your standard follow-up imaging will be done using an FDA approved DBT system, but it will be different from the DBT system used for your routine screening. For example, if narrow-angle DBT was used for your routine screening, then you will have standard wide-angle DBT. If wide-angle DBT used for your routine screening, then you will have narrow-angle DBT. These images will be used for diagnosis and to help decide your further care.

Interventions

Digital Breast Tomosynthesis (DBT)

Undergo tomosynthesis imaging

Primary outcome measure

  • Safety and adverse events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts and Locations

Central contacts

Locations

MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Principal Investigator:

Beatriz Adrada, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

May 4, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-05-04.